The novel sequence-specific DNA cross-linking agent SJG-136 (NSC 694501) has potent and selective in vitro cytotoxicity in human B-cell chronic lymphocytic leukemia cells with evidence of a p53-independent mechanism of cell kill

Cancer Research
Christopher J PepperDavid E Thurston

Abstract

SJG-136 (NSC 694501) is a novel DNA cross-linking agent that binds in a sequence-selective manner in the minor groove of the DNA helix. It is structurally novel compared with other clinically used DNA cross-linking agents and has exhibited a unique multilog differential pattern of activity in the NCI 60-cell line screen (i.e., is COMPARE negative to other cross-linking agents). Given this profile, we undertook a preclinical evaluation of SJG-136 in primary tumor cells derived from 34 B-cell chronic lymphocytic leukemia (B-CLL) patients. SJG-136 induced apoptosis in all of the B-CLL samples tested with a mean LD50 value (the concentration of drug required to kill 50% of the cells) of 9.06 nmol/L. Its cytotoxicity was undiminished in B-CLL cells derived from patients treated previously, those with unmutated VH genes, and those with p53 mutations (P=0.17; P=0.63; P=0.42, respectively). SJG-136-induced apoptosis was associated with the activation of caspase-3 that could be partially abrogated by the caspase-9 inhibitor Z-LEHD-FMK. Furthermore, SJG-136 did not trigger the phosphorylation of p53 or the up-regulation of GADD45 expression in B-CLL cells whereas the cross-linking agent chlorambucil elicited both of these effects. This s...Continue Reading

References


❮ Previous
Next ❯

Citations

Dec 29, 2010·Cancer Chemotherapy and Pharmacology·Joel M ReidMatthew M Ames
Apr 2, 2005·Nature Reviews. Cancer·Stephen Neidle, David E Thurston
May 2, 2012·The Journal of Antimicrobial Chemotherapy·Khondaker M RahmanPeter W Taylor
Apr 5, 2011·Expert Opinion on Investigational Drugs·John A Hartley
Jun 15, 2010·Medicinal Research Reviews·Barbara Gerratana
Jul 28, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S M GuichardD I Jodrell
Sep 30, 2016·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Yong MaDonglu Zhang
Mar 21, 2018·Targeted Oncology·Cédric RossiRené-Olivier Casasnovas
Aug 16, 2008·Molecular BioSystems·Paul BrennanSaman Hewamana
Apr 3, 2007·Journal of Combinatorial Chemistry·Dyeison AntonowDavid E Thurston

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis